🇺🇸 FDA

Intelligence · Clinical Pipeline

BRIGHT MINDS BIOSCIENCES Pipeline

All ClinicalTrials.gov programs at BRIGHT MINDS BIOSCIENCES — phase, modality, and trial IDs.

Programs
393

Quick answer

BRIGHT MINDS BIOSCIENCES has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. Mirtazapine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  2. Mirtazapine

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule completed

    1 trial

  3. Mirtazapine 15 MG Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  4. Mixed-Amphetamine Salts- Extended Release (MAS-ER)

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  5. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule active

    2 trials

  6. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    2 trials

  7. Modafinil

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    3 trials

  8. Modafinil 0 mg

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  9. Modafinil 200mg

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Abuse

    phase 2 small molecule terminated

    1 trial

  10. Monitoring and Feedback Intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  11. Mood Management Phone Counseling for Smoking Cessation

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    phase 2 other completed

    1 trial

  12. Motivational enhancement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Abuse

    phase 2 other completed

    1 trial

  13. Motivational interviewing

    BRIGHT MINDS BIOSCIENCES INC.

    Adherence

    phase 2 other active

    1 trial

  14. Moxifloxacin (M)

    BRIGHT MINDS BIOSCIENCES INC.

    Pulmonary Tuberculosis

    phase 2 small molecule completed

    1 trial

  15. Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 2 small molecule completed

    1 trial

  16. Multimedia WORTH

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  17. N Acetyl Cysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Gambling

    phase 2 small molecule completed

    1 trial

  18. N-Acetylcysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    2 trials

  19. N-acetylcysteine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  20. N-acetylcysteine (NAC)

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  21. NAP (Naptumomab estafenatox)

    BRIGHT MINDS BIOSCIENCES INC.

    Non-small Cell Lung Cancer

    phase 2 small molecule completed

    1 trial

  22. Nab paclitaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Metastatic Pancreatic Cancer

    phase 2 small molecule terminated

    1 trial

  23. Nabilone

    BRIGHT MINDS BIOSCIENCES INC.

    Frontotemporal Dementia

    phase 2 small molecule active

    1 trial

  24. Nabilone

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 2 small molecule terminated

    1 trial

  25. Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol Dependence

    phase 2 small molecule completed

    1 trial

  26. Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Alcohol-Related Disorders

    phase 2 small molecule completed

    3 trials

  27. Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 2 small molecule completed

    3 trials

  28. Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Stable Opioid Dependence

    phase 2 small molecule completed

    1 trial

  29. Naltrexone (drug)

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    phase 2 small molecule completed

    1 trial

  30. Naltrexone hydrochloride

    BRIGHT MINDS BIOSCIENCES INC.

    Obesity

    phase 2 small molecule active

    1 trial

  31. Navigating my Journey program

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    phase 2 other completed

    1 trial

  32. Nefazodone

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  33. Nepicastat

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine Dependence

    phase 2 small molecule completed

    1 trial

  34. NicVAX

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 mab completed

    1 trial

  35. NicVAX conjugate vaccine

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    phase 2 mab completed

    1 trial

  36. Nicotine 0 mg/mL

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine

    phase 2 small molecule completed

    1 trial

  37. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Tobacco Use Disorder

    phase 2 small molecule completed

    2 trials

  38. Nicotine gum and lozenge

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    phase 2 small molecule completed

    1 trial

  39. Nicotine replacement

    BRIGHT MINDS BIOSCIENCES INC.

    Cardiovascular Disease

    phase 2 small molecule completed

    1 trial

  40. Nimodipine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    phase 2 small molecule completed

    1 trial

  41. Nitrous oxide

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-Related Disorders

    phase 2 small molecule completed

    1 trial

  42. OND-PR002 and MPh-IR

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    1 trial

  43. ORY-2001 Low dose

    BRIGHT MINDS BIOSCIENCES INC.

    Mild to Moderate Alzheimer's Disease

    phase 2 small molecule completed

    1 trial

  44. Omnitram Oral Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Diabetic Neuropathies

    phase 2 small molecule completed

    1 trial

  45. Ondansetron

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 2 small molecule completed

    1 trial

  46. Opioid-Related Disorders

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    phase 2 small molecule terminated

    3 trials

  47. Oral Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 small molecule completed

    1 trial

  48. Oshadi Icp

    BRIGHT MINDS BIOSCIENCES INC.

    Diabetes Mellitus, Insulin-Dependent, 1

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many pipeline programs does BRIGHT MINDS BIOSCIENCES have?

393 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.